Andrew W Bergen
Overview
Explore the profile of Andrew W Bergen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
118
Citations
4950
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Duffy M, Rogers M, Joiner T, Bergen A, Berrettini W, Bulik C, et al.
Int J Eat Disord
. 2019 Jan;
52(2):200-205.
PMID: 30636025
Objective: This study examined a hypothesized pathway by which interoceptive dysfunction accounted for associations between personality features (harm avoidance, self-directedness, and perfectionism) and anorexia nervosa (AN) severity (indicated by drive...
22.
Thornton L, Munn-Chernoff M, Baker J, Jureus A, Parker R, Henders A, et al.
Contemp Clin Trials
. 2018 Oct;
74:61-69.
PMID: 30287268
Background: Genetic factors contribute to anorexia nervosa (AN); and the first genome-wide significant locus has been identified. We describe methods and procedures for the Anorexia Nervosa Genetics Initiative (ANGI), an...
23.
Anttila V, Bulik-Sullivan B, Finucane H, Walters R, Bras J, Duncan L, et al.
Science
. 2018 Jun;
360(6395).
PMID: 29930110
Disorders of the brain can exhibit considerable epidemiological comorbidity and often share symptoms, provoking debate about their etiologic overlap. We quantified the genetic sharing of 25 brain disorders from genome-wide...
24.
Johansson J, Brubaker W, Javitz H, Bergen A, Nishita D, Trigunaite A, et al.
Alzheimers Dement
. 2018 May;
14(11):1438-1449.
PMID: 29792870
Introduction: Genome-wide association studies consistently show that single nucleotide polymorphisms (SNPs) in the complement receptor 1 (CR1) gene modestly but significantly alter Alzheimer's disease (AD) risk. Follow-up research has assumed...
25.
Baurley J, McMahan C, Ervin C, Pardamean B, Bergen A
Trends Mol Med
. 2018 Feb;
24(2):221-235.
PMID: 29409736
There are limited biomarkers for substance use disorders (SUDs). Traditional statistical approaches are identifying simple biomarkers in large samples, but clinical use cases are still being established. High-throughput clinical, imaging,...
26.
27.
Legason I, Pfeiffer R, Udquim K, Bergen A, Gouveia M, Kirimunda S, et al.
EBioMedicine
. 2017 Oct;
25:58-65.
PMID: 29033373
Background: Plasmodium falciparum (Pf) malaria infection is suspected to cause endemic Burkitt Lymphoma (eBL), but the evidence remains unsettled. An inverse relationship between sickle cell trait (SCT) and eBL, which...
28.
Schuit E, Panagiotou O, Munafo M, Bennett D, Bergen A, David S
Cochrane Database Syst Rev
. 2017 Sep;
9:CD011823.
PMID: 28884473
Background: Smoking cessation therapies are not effective for all smokers, and researchers are interested in identifying those subgroups of individuals (e.g. based on genotype) who respond best to specific treatments....
29.
Chen L, Zawertailo L, Piasecki T, Kaprio J, Foreman M, Elliott H, et al.
Nicotine Tob Res
. 2017 May;
20(4):414-424.
PMID: 28498934
This article outlines a framework for the consistent integration of biological data/samples into smoking cessation pharmacotherapy trials, aligned with the objectives of the recently unveiled Precision Medicine Initiative. Our goal...
30.
Landi M, Chatterjee N, Yu K, Goldin L, Goldstein A, Rotunno M, et al.
Am J Hum Genet
. 2017 May;
88(6):861.
PMID: 28472664
No abstract available.